SS-31 (Elamipretide): Research Overview

SS-31 (Szeto-Schiller peptide 31; elamipretide) is an aromatic-cationic tetrapeptide that selectively concentrates in the inner mitochondrial membrane. It is studied for mitochondrial protection, reduction of reactive oxygen species, and bioenergetics.

Cardiolipin targeting

SS-31's alternating cationic and aromatic residues cause it to selectively partition into the inner mitochondrial membrane, where it binds cardiolipin — a phospholipid essential to cristae structure and to the organization of respiratory-chain supercomplexes. By stabilizing cardiolipin, SS-31 is reported to reduce electron leak, superoxide generation, and cytochrome c release.

Bioenergetics and disease-model research

Animal models of heart failure, ischemia-reperfusion injury, and age-related mitochondrial dysfunction have reported improvements in ATP production and reductions in oxidative stress with SS-31 treatment. A clinical trial (EMBRACE-HF) reported improvements in heart-failure biomarkers. SS-31 is studied alongside MOTS-c as a mitochondrially-targeted longevity research compound.

Purity and verification

Pokai Research SS-31 is supplied as a research-grade tetrapeptide at 99.2% purity. Batch-specific Certificate of Analysis documentation is available on request via the product page.

Frequently asked questions

What is SS-31 and what is its proposed role in mitochondrial membrane protection?

SS-31 (Szeto-Schiller peptide 31; elamipretide) is a tetrapeptide with the sequence D-Arg-2'6'-dimethylTyr-Lys-Phe-NH2 that selectively partitions into the inner mitochondrial membrane due to its alternating cationic and aromatic residues. Research indicates it binds cardiolipin — a lipid essential for cristae structure and the organization of respiratory chain supercomplexes — thereby reducing electron leak, superoxide generation, and cytochrome c release. Animal models of heart failure, ischemia-reperfusion injury, and age-related mitochondrial dysfunction have demonstrated improvements in ATP production and reductions in oxidative stress with SS-31 treatment.

Source: J Am Heart Assoc (2016) · PubMed

How does mitochondrial dysfunction relate to aging?

The mitochondrial theory of aging posits that cumulative damage to mitochondrial DNA, membranes, and respiratory chain complexes reduces ATP production efficiency and increases reactive oxygen species (ROS) generation over time. This creates a positive feedback loop: ROS damage mitochondrial components further, impairing energy production and accelerating cellular senescence. Research in model organisms has demonstrated that interventions restoring mitochondrial biogenesis (via PGC-1α activation), reducing electron leak, or enhancing mitophagy can extend healthy lifespan. Peptides targeting these mitochondrial pathways — including MOTS-c and SS-31 — are of active research interest in the context of aging biology.

Source: Cell (2013) · PubMed

How is peptide purity measured and why does it matter?

Peptide purity is typically assessed by reverse-phase high-performance liquid chromatography (HPLC) and confirmed by mass spectrometry. These techniques quantify the proportion of the target compound relative to impurities such as deletion sequences, oxidized variants, or solvent residues. Research applications require high purity — commonly ≥98% — to ensure that observed biological effects can be attributed to the intended molecule rather than contaminants. Independent third-party certificates of analysis (COAs) provide an objective record of purity at the time of synthesis.

Source: J Pept Sci (2019) · PubMed

What is a Certificate of Analysis (COA)?

A Certificate of Analysis (COA) is a document from an accredited analytical laboratory confirming a compound's identity, purity, and potency. For research peptides it typically includes HPLC chromatograms and mass spectrometry data. Independent third-party COAs are the gold standard for verifying compound quality.

Source: USP General Chapter ⟨1058⟩ · PubMed

View SS-31 in the catalog →